Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600513'
s Days Inventory Range Over the Past 10 Years
Min: 84.56 Med: 118.39 Max: 148.19
Current: 111.77
During the past 13 years, Jiangsu Lianhuan Pharmaceutical Co's highest Days Inventory was 148.19. The lowest was 84.56. And the median was 118.39.
SHSE:600513's Days Inventory is ranked better than 74.27% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs SHSE:600513: 111.77
Inventory Turnover measures how fast the company turns over its inventory within a year.
Jiangsu Lianhuan Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jiangsu Lianhuan Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.79.
Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Jiangsu Lianhuan Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Jiangsu Lianhuan Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Jiangsu Lianhuan Pharmaceutical Co Days Inventory Related Terms
Jiangsu Lianhuan Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Lianhuan Pharmaceutical Co Days Inventory Chart
SHSE:600513 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Lianhuan Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) has a Days Inventory of 97.95 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors. This is 17% below median its historical median of 118.39. Over the past decade, Jiangsu Lianhuan Pharmaceutical Co's Days Inventory has ranged from 84.56 to 148.19. According to the industry distribution chart, Jiangsu Lianhuan Pharmaceutical Co ranks #237 out of 921 companies in the Drug Manufacturers industry, placing it in the top 25.7%.
Is Jiangsu Lianhuan Pharmaceutical Co's Days Inventory too high?
Jiangsu Lianhuan Pharmaceutical Co's current Days Inventory of 97.95 is 17% below median its 10-year median of 118.39. Over the past 10 years, this metric has ranged from a low of 84.56 to a high of 148.19. The Drug Manufacturers industry median Days Inventory is 164.48. Jiangsu Lianhuan Pharmaceutical Co's value of 97.95 is 40.4% below this industry median. Based on the distribution chart, Jiangsu Lianhuan Pharmaceutical Co ranks #237 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jiangsu Lianhuan Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Lianhuan Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Lianhuan Pharmaceutical Co ranks #237 out of 921 companies for Days Inventory. This puts Jiangsu Lianhuan Pharmaceutical Co in the upper half of its industry. The industry median Days Inventory is 164.48. Jiangsu Lianhuan Pharmaceutical Co's value of 97.95 is 40.4% below this benchmark. Historically, Jiangsu Lianhuan Pharmaceutical Co's own Days Inventory has ranged from 84.56 to 148.19 over the past decade. While the company's 10-year median is 118.39 vs. the industry median of 164.48, Jiangsu Lianhuan Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Lianhuan Pharmaceutical Co's current Days Inventory of 97.95 is 40.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Lianhuan Pharmaceutical Co's current Days Inventory is 97.95, which is 17% below median its own 10-year median of 118.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Lianhuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥13.72, compared to a current price of ¥15.42 — trading 12.4% above its estimated fair value. The current Days Inventory is 97.95, which is 17% below median its 10-year median of 118.39 and 40.4% below the Drug Manufacturers industry median of 164.48. Jiangsu Lianhuan Pharmaceutical Co's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513), the current Days Inventory is 97.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥15.42 is trading 12.4% above its estimated GF Value™ of ¥13.72.
GuruFocus considers Jiangsu Lianhuan Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for SHSE:600513:
Days Inventory: 97.95 (17% below median its 10-year median of 118.39)
GF Value™: ¥13.72 vs. price of ¥15.42 (12.4% above fair value)
Industry Position: 40.4% below the Drug Manufacturers median (#237 of 921)
No single metric tells the full story. See the SHSE:600513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Lianhuan Pharmaceutical Co Business Description
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
65GF Score
Get the complete analysis for SHSE:600513
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600513 has been successfully added to your 
